Skip to main content
. Author manuscript; available in PMC: 2012 Dec 9.
Published in final edited form as: Circ Res. 2011 Oct 13;109(12):1396–1400. doi: 10.1161/CIRCRESAHA.111.255687

Table 1.

Quantitation of western blotting from Figure 2*.

Control MI ±SE N RBX MI ±SE N

P-PLN S16 1 0.1484 6 0.6989 0.1323 6
P-PLN T17 1 0.1686 6 0.6179 0.1808 6
P-CaV1.2 S1928 1 0.06157 6 0.9453 0.07016 6
P-RyR2 S2808 1 0.07453 6 1.007 0.04664 6
P-RyR2 S2814 1 0.09668 6 1.174 0.04865 6
P-TnI S23/24 1 0.07356 6 1.02 0.09644 6
P-TnI T143 1 0.03434 6 0.9662 0.04292 6
P-MyBP-C S273 1 0.06311 6 1.012 0.08399 6
P-MyBP-C S282 1 0.1388 6 1.185 0.1676 6
P-MyBP-C S302 1 0.07872 6 0.9289 0.06183 6
P-PKCα/β/γ T638 1 0.02391 6 0.9056 0.08258 6
P-PKCα S657 1 0.06466 6 1.056 0.08495 6
PKCα 1 0.04457 6 0.8684 0.07415 6
PKCβI 1 0.09436 6 0.949 0.1308 6
PKCβII 1 0.07333 6 0.8084 0.1281 6
PKCγ 1 0.08483 6 0.7911 0.1233 6
*

None of the values were significantly different between treated and untreated controls. N=6 ventricular samples from 3 different animals (2 samples each).